Patents by Inventor Rachel Nachman

Rachel Nachman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6737547
    Abstract: The present invention provides novel aminoindenes having the structure: wherein n is 1 or 2, R1 is hydrogen, linear or branched chain C1-C8 alkyl or linear or branched chain C1-C8 alkoxy and R2 is hydrogen or a halogen. Such compounds may be used to treat neurodegenerative conditions such as Alzheimer's disease, head trauma, stroke, hypoxia, anoxia, epilepsy, convulsions, seizures.
    Type: Grant
    Filed: September 15, 1999
    Date of Patent: May 18, 2004
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Benjamin Sklarz, Sasson Cohen, Tzipora Speiser, Rachel Nachman
  • Patent number: 5565462
    Abstract: Use of a compound selected from the group consisting of pentoxifylline, propentofylline and torbafylline for topical treatment of psoriasis or atopic dermatitis and pharmaceutical compositions comprising them.
    Type: Grant
    Filed: June 21, 1994
    Date of Patent: October 15, 1996
    Assignees: Teva Pharmaceutical Industries, Ltd., Ramot University for Applied Research and Industrial Development, Ltd.
    Inventors: Anat Eitan, Rachel Nachman, Sasson Cohen